Valneva COVID-19 Vaccine: Can We Rely on This 'Variant Proof' Shot?
Close The Valneva COVID-19 vaccine is said to be reliant in terms of its reliance against the virus. This shot from the French company, Valneva, has yet to reach completion of his clinical trials. However, according to Rappler, the vaccine has caught the eye of governments, specifically in Australia, Europe, and the United Kingdom. One of the main selling points of this vaccine is its seeming ability to mount a more common immune reaction against SARS-CoV-2, the virus that causes COVID-19, instead of depending on the spike protein to do this. Meaning, the vaccine is more possible to be effect...
Source: sciencetimes.com